-transparent.png){kind=logo}
In order to examine the clinical features of severe acute exacerbation in chronic hepatitis B virus (HBV) infection, 297 hepatitis B surface antigen (HBsAg) carriers were followed for 35 +/- 22 months (mean +/- S.D.) in Tohoku University Hospital from 1976 to 1987. Of these, 10 experienced severe acute exacerbation with hepatic decompensation. All of these patients had intense subjective symptoms related to the hepatitis. They were all icteric and 8 had ascites. Three developed to fulminant hepatic failure, eventually died. Histology after the exacerbation showed severe hepatic damage such as massive hepatic necrosis and bridging hepatic necrosis in a half of them. Six cases were suspected to result from spontaneous reactivation and 2 from drug-induced reactivation of chronic HBV infection, and the other 2 from superinfection with non-A, non-B hepatitis agent (s). These results suggest that the reactivation of chronic HBV infection is an important factor of severe acute exacerbations in chronic HBV infection in Japan.
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
January 1996,
Revista da Sociedade Brasileira de Medicina Tropical,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
October 1993,
Gastroenterology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
January 2016,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
November 2015,
International journal of molecular sciences,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
January 2014,
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
February 2001,
The American journal of gastroenterology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
May 2019,
World journal of gastroenterology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
December 2013,
European journal of gastroenterology & hepatology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
September 2012,
Journal of gastroenterology,
A Kanno, and
H Suzuki, and
Y Miyazaki, and
S Sato, and
M Otsuki, and
Y Goto, and
H Ohori
January 2015,
Antimicrobial agents and chemotherapy,
